Trial Profile
Early Access of TMC125 in Combination With Other Antiretrovirals in Treatment-Experienced HIV-1 Infected Subjects With Limited Treatment Options.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Jun 2015
Price :
$35
*
At a glance
- Drugs Etravirine (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Janssen R&D Ireland
- 01 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Sep 2011 Additional trial location (Switzerland) identified as reported by ClinicalTrials.gov.